Litcius/Paper detail

<i>Fusobacterium nucleatum</i> induces MDSCs enrichment <i>via</i> activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance

Mengxia Liang, Yiwen Liu, Zheyuan Zhang, Haijun Yang, Ningtao Dai, Ning Zhang, Wei Sun, Yibo Guo, Jinyu Kong, Xiaopeng Wang, Min Wang, Fuyou Zhou

2022Annals of Medicine49 citationsDOIOpen Access PDF

Abstract

BACKGROUND: (Fn) on NOD-like receptor protein 3 (NLRP3) and myeloid-derived suppressor cells (MDSCs) in oesophageal squamous cell carcinoma (ESCC) as well as its effect on cisplatin (CDDP) therapy and to explore its clinical significance. METHODS: models were used to analyse the effects of Fn on the percentage of MDSCs in the coculture system and the NLRP3 expression level and CDDP sensitivity of ESCC cells. RESULTS: models, Fn induced abundant enrichment of MDSCs by inducing high expression of NLRP3 in ESCC cells and reducing the sensitivity of ESCC cells to CDDP. CONCLUSIONS: Fn infection can induce high expression of NLRP3 in ESCC, lead to MDSCs enrichment, weaken the body's antitumour immunity, and lead to CDDP treatment resistance. The effective elimination of Fn and the inhibition of MDSCs enrichment may provide new strategies and treatments for ESCC.HighlightsThe survival of ESCC patients with Fn infection, high NLRP3 expression and MDSCs enrichment was significantly shortened.Fn infection could cause CDDP resistance in ESCC.Fn could induce the enrichment of MDSCs in the tumour microenvironment by activating NLRP3 in ESCC cells.

Topics & Concepts

Fusobacterium nucleatumCancer researchIn vitroIn vivoCisplatinImmune systemBiologyImmunologyMedicineInternal medicineChemotherapyPorphyromonas gingivalisPeriodontitisBiotechnologyBiochemistryImmune cells in cancerImmune Response and InflammationInflammation biomarkers and pathways
<i>Fusobacterium nucleatum</i> induces MDSCs enrichment <i>via</i> activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance | Litcius